Weak links: How corruption affects the quality and integrity of medical products and impacts on the Covid-19 response

dc.contributor.author	Steingrüber, Sarah
dc.contributor.author	Gadanya, Muktar
dc.date.accessioned	2022-03-09T17:24:13Z
dc.date.available	2022-03-09T17:24:13Z
dc.date.issued	2021-12-01
dc.identifier	oai:www.cmi.no:8260
dc.identifier.citation	Bergen: Chr. Michelsen Institute (U4 Issue 2021:15)
dc.identifier.uri	https://hdl.handle.net/11250/2984114
dc.description.abstract	Corruption is involved in poor medical product quality in five important areas: manufacturing and distribution, regulation, procurement, high-level governance, and the health workforce. Existing corruption pressures impact the quality of medicines, and the Covid-19 pandemic has amplified the proliferation of falsified medical products. Innovative and existing anti-corruption approaches concentrate on prevention, detection, and response.
dc.language.iso	eng
dc.publisher	Chr. Michelsen Institute
dc.relation	U4 Issue
dc.relation	2021:15
dc.relation.ispartof	U4 Issue
dc.relation.ispartofseries	U4 Issue 2021:15
dc.relation.uri	https://www.cmi.no/publications/8260-weak-links-how-corruption-affects-the-quality-and-integrity-of-medical-products-and-impacts-on-the
dc.subject	Anti-Corruption Measures
dc.subject	Artificial Intelligence
dc.subject	Blockchain
dc.subject	Covid-19
dc.subject	Fraud Detection
dc.subject	Health Sector
dc.subject	Pharmaceuticals
dc.subject	Public Procurement
dc.subject	Public Sector
dc.title	Weak links: How corruption affects the quality and integrity of medical products and impacts on the Covid-19 response
dc.type	Research report